World Health Organsiaton
- Says pause in AstraZeneca’s COVID-19 vaccine trial show it is a ‘well-run’ trial.
- Shows that they have looked at safety in ‘an appropriate manner’
AstraZeneca gaining credibility with their cautious approach. Astra Zeneca up 2% on the day.